American Healthcare REIT, Inc. (AHR) Stock Analysis
Market Closed
Sector: Real Estate · Industry: Real Estate Investment Trusts
What's happening with AHR
Price History
5-Year Weekly Candlestick Chart
Profile
profitability and growth lag behind.
How is each axis scored?
- Valuation52/100 · Moderate
- P/E vs own history (26th pct)20/25
- FCF yield (n/a)10/25
- P/S (5.2x)12/25
- EV/EBIT (n/a)10/25
- Growth45/100 · Weak
- Revenue CAGR (14.0%)20/25
- Net income CAGR (n/a)0/25
- EPS CAGR 5Y (n/a)0/25
- Fwd implied growth (38.0%)25/25
- Profitability21/100 · Weak
- ROIC (1.8%)5/25
- ROE (2.9%)5/25
- Net margin (4.6%)6/25
- Operating margin (3.6%)5/25
- Financial Health52/100 · Moderate
- Altman Z (2.57)18/25
- Current ratio (0.70)6/25
- Interest coverage (1.2x)3/25
- Net cash / debt (Net cash)25/25
- Quality65/100 · Moderate
- Piotroski F (6/9)15/25
- Beneish M (-2.63)25/25
- FCF conversion (n/a)0/25
- Margin stability (σ 3.0%)25/25
About American Healthcare REIT, Inc.
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. Show more
It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office buildings, skilled nursing facilities, senior housing, hospitals, and other healthcare-related facilities. It has four reportable business segments: integrated senior health campuses, outpatient medical, triple-net leased properties and SHOP. It generates majority of its revenue through Integrated Senior Health Campuses segment.
Headquarters: IRVINE, CA · Employees: 121 · Website ↗
Analyst Consensus
Strong BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 21, 2026
Insider Transactions
Recent SEC Form 4 filings
- BuyGrant / award · filed 2026-08-04+2.6K sh2026-07-21
- BuyGrant / award · filed 2026-07-22+6.0K sh2026-07-21
- SellOption exercise · filed 2026-07-22-20912 sh2026-07-21
- SellOption exercise · filed 2026-07-22-30886 sh2026-07-21
- BuyGrant / award · filed 2026-07-22+2.6K sh2026-07-21
+3 more recent filings
Key Metrics
Financial snapshot — pillar inputs plus per-share and market context
Valuation
52CP/E (TTM)98.0xD
Grade D: Exp.Price / TTM EPS (own statements) — vs own 3Y history: 85.6x–325.6x · 26th pct
P/FCF146.9xD
Grade D: Exp.Price / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative
FCF Yield0.7%C
Grade C: LowTTM FCF / Market Cap
P/S (TTM)5.17xC
Grade C: Exp.Price / TTM Revenue (own statements) — vs own 3Y history: 0.5x–4.9x · highest in history
EV/EBITDA33.1xD
Grade D: Exp.Enterprise value / EBITDA (Finnhub) — capital-structure neutral
EV/Sales5.1xC
Grade C: Exp.Enterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple
Forward P/E71.0xD
Grade D: Exp.Price / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth
P/B Ratio3.27xC
Grade C: Exp.Price to Book Value. Neg. equity = heavy buybacks
PEG Ratio3.82D
Grade D: Exp.Finnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)
Dividend Yield1.55%A
Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress
Payout Ratio234.3%D
Grade D: Unsust.Dividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable
Profitability
21EROIC1.8%D
Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat
ROE2.9%D
Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks
ROA2.3%D
Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit
Net Margin4.6%D
Grade D: LowNet Income / Revenue
Operating Margin3.6%D
Grade D: LowTTM EBIT / TTM Revenue
Gross Margin15.0%D
Grade D: LowGross Profit / Revenue
FCF Margin—
FCF / Revenue
True FCF Margin—
TTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost
Financial Health
52CAltman Z-Score2.57C
Grade C: Gray zoneBankruptcy risk. >3 Safe, <1.8 Distress
Current Ratio0.70xD
Grade D: LowCurrent Assets/Liabilities
Quick Ratio0.70xC
Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory
Interest Coverage1.2xD
Grade D: RiskyEBIT/Interest. >10 Strong
Debt Repayment—
Years to repay net debt via FCF
Net Debt/EBIT—
Leverage. <2x Low, >4x High
Debt/Equity0.47xA
Grade A: LowDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.
Cash / Debt—
Cash covers how much of total debt. >1 = could repay all debt from cash
Growth
45D+Revenue CAGR14.0%C
Grade C: OkCompound annual revenue growth (up to 5Y depending on data availability)
Net Income CAGR—
Compound annual net income growth (up to 5Y depending on data availability)
EPS CAGR (5Y)—
Compound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0
Forward Growth38.0%A
Grade A: HighImplied 1Y EPS growth from forward P/E vs our TTM EPS. Sparse — only where forward estimates exist
Dilution (5Y)—
Share count change over 5Y
SBC / Net Income16.9%C
Grade C: MedStock-based comp/Net income. >30% = dilution risk
SBC / Revenue0.8%A
Grade A: LowTTM stock-based comp / TTM Revenue
Quality
3/4 Loss Years65BPiotroski F-Score6/9C
Grade C: AvgFinancial strength 0–9. >7 Strong
Beneish M-Score-2.63A
Grade A: SafeEarnings manipulation risk. < -2.22 Safe
FCF Conversion—
FCF / Net Income
Margin Stability3.0%A
Grade A: StableEBIT margin std deviation. Lower = stable
Capex / Revenue—
TTM CapEx / TTM Revenue — high % = capital-hungry business
Asset Turnover0.42xD
Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales
Per Share
EPS (TTM)$0.53
Own TTM net income / shares — same earnings basis as P/E
Cash / Share$0.49
Cash & short-term investments per share (Finnhub)
Book Value / Share$14.36
Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks
Balance Sheet
Total Debt—
Total debt obligations (short + long term)
Cash & Equiv.$119.38M
Cash and short-term investments
Net Debt—
Total Debt minus Cash. Negative = Net Cash position
Total Equity$3.48B
Shareholders' equity (book value)
Asset / Liability2.70xA
Grade A: SolidTotal Assets / Total Liabilities
Market
Market Cap$11.40B
Current Market Capitalization
Beta0.82B
Grade B: MarketPrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings
Takeaway
AHR predstavuje neatraktívnu a rizikovú investíciu kvôli slabej profitabilite, chýbajúcemu voľnému cash flow a hraničnému finančnému zdraviu v šedej zóne.
Current P/E of 98.0x sits at the 26th percentile of its historical range.
How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.
Financials as of Mar 2026 · Ratio snapshot Sep 22, 2026
Key Insights: American Healthcare REIT, Inc. (AHR)
Composite verdict for American Healthcare REIT, Inc.: AHR predstavuje neatraktívnu a rizikovú investíciu kvôli slabej profitabilite, chýbajúcemu voľnému cash flow a hraničnému finančnému zdraviu v šedej zóne.. Piotroski F-Score of 6/9 indicates mixed fundamentals for American Healthcare REIT, Inc.. Altman Z-Score of 2.57 falls in the grey zone (1.81–2.99) — financial distress is unlikely but not ruled out.
- Beneish M-Score of -2.63 suggests a low likelihood of earnings manipulation.
- Interest coverage of 1.2× leaves little room for earnings shocks.
- American Healthcare REIT, Inc. posted a net loss in 3 of 4 available completed fiscal years (2022–2025).
See how AHR ranks on the Capex Tracker — top 50 capital spenders compared.
No significant market moves for AHR in the last 30 days.
See AHR move history →Frequently Asked Questions about AHR
Is AHR stock a buy right now?
PreMarketPrice's quantitative model rates American Healthcare REIT, Inc.'s financial health at 52/100 — AHR predstavuje neatraktívnu a rizikovú investíciu kvôli slabej profitabilite, chýbajúcemu voľnému cash flow a hraničnému finančnému zdraviu v šedej zóne.. This is a data-driven snapshot of fundamentals, not investment advice.
Is AHR stock overvalued?
American Healthcare REIT, Inc. trades at a trailing P/E of 98.0 and our valuation score rates it 52/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.
When does American Healthcare REIT, Inc. report earnings?
No confirmed earnings date is currently scheduled for AHR. The Earnings section lists recent reports and updates as dates are announced.
What sector does American Healthcare REIT, Inc. operate in?
American Healthcare REIT, Inc. operates in the Real Estate sector, within the Real Estate Investment Trusts industry. The Related Stocks section lists sector peers for comparison.
What does American Healthcare REIT, Inc. do?
American Healthcare REIT Inc is a healthcare-focused real estate investment trust.
About American Healthcare REIT, Inc. (AHR) Stock
American Healthcare REIT, Inc. (AHR) is a US-listed stock operating in the Real Estate sector, specifically the Real Estate Investment Trusts industry. Real-time pricing data for American Healthcare REIT, Inc. is available on this page with a market capitalization of $11.4 billion. The financial health score for AHR is 52/100, which indicates moderate financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for AHR stock.
AHR Stock Analysis & Key Metrics
On PreMarketPrice, you can track American Healthcare REIT, Inc. (AHR) across multiple dimensions:
- Pre-market price & movement: Real-time AHR stock price with percentage change, updated continuously during pre-market and regular trading hours.
- Valuation & P/E history: Historical P/E, P/S, and P/B ratios for AHR with trend analysis and normalized valuation multiples.
- Financial statements: Revenue, net income, assets, liabilities, and equity for American Healthcare REIT, Inc. across multiple reporting periods.
- Financial health score: A composite score of 52/100 based on Altman Z-Score, Piotroski F-Score, profitability, and leverage metrics for AHR.
- Sector peers: Compare AHR against 10 other real estate stocks on key financial metrics.
Is AHR a Good Stock to Buy?
This page provides data-driven analysis to help you evaluate American Healthcare REIT, Inc. (AHR) as an investment. The financial health score of 52/100 suggests moderate financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.
Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.American Healthcare REIT, Inc. (AHR) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.